The technology

Novlead's core NO technology is divided into two categories, one of which is the sustained release technology based on NO donors. Our advantages in donor design, development and process production, combined with in-depth research on various loading materials and technologies allow us to provide NO sustained-releasing materials in response to different needs to achieve anticoagulation and antimicrobial effect.

Product applications

• INOwill N100 uses electrochemical catalytic reduction and gas-liquid separation technology combined with an intelligent gas delivery system to produce NO at the desired flow rate and concentration. There is no excessive NO generation and this minimizes the NO2 by-product which is toxic to the patients.

• INOwill N200 is the next-generation model on top of INOwill N100. It is designed to treat pulmonary hypertension caused by various reasons, pulmonary fibrosis and COPD in the combined use with different models of ventilators. N200 senses the output gas changes in milliseconds which then advises the NO reaction in real-time to respond to the patient’s inhale and exhale pattern.

• INOcure uses photolysis and real-time feedback technology to generate NO gas with controllable flow rate and concentration, which can be used for wound healing and treating diabetic feet.